CRISPR: How Far Could Gene Editing Go?

CRISPR changed biological research by making targeted genetic interventions easier to programme. This episode follows the idea from microbial defence to approved treatment, explaining how a DNA cut becomes an edit and why the cell's response matters as much as the targeting tool. Understand what Casgevy demonstrated, why a one-time infusion can still involve a demanding treatment pathway, and how base editing and personalised approaches are extending the toolkit. We also examine cancer research, agriculture, livestock and gene drives, separating plausible uses from claims that biology has become completely programmable. The final questions concern people as much as molecules: who can access treatment, how future generations should be protected, and what communities should decide before an intervention affects them. A clear account of gene editing's achievements, remaining risks and ethical boundaries. Follow Taylor Tailored for more evidence-led science.